Overview

Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema (DIAMOND-2)

Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the efficacy and safety of OCS 01 as compared to Vehicle in subjects with Diabetic Macular Edema (DME).
Phase:
Phase 3
Details
Lead Sponsor:
Oculis
Collaborator:
ICON plc
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate